Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul 16;11(1):15.
doi: 10.1186/s40413-018-0194-3. eCollection 2018.

Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study

D Samreth  1 S Arnavielhe  1 F Ingenrieth  2 A Bedbrook  3 G L Onorato  3 R Murray  4 R Almeida  5 M A Mizani  6 J Fonseca  5 E Costa  7 J Malva  8 M Morais-Almeida  9 A M Pereira  10 A Todo-Bom  11 E Menditto  12 C Stellato  13 M T Ventura  14 D Larenas-Linnemann  15 J-M Fuentes-Pérez  16 Y R Huerta-Villalobos  16 A A Cruz  17 R Stelmach  18 J da Silva  19 R Emuzyte  20 V Kvedariene  21 A Valiulis  22   23 I Annesi-Maesano  24 I Bosse  25 P Demoly  26 P Devillier  27 J F Fontaine  28 P Kuna  29 B Samolinski  30 L Klimek  31 R Mösges  32   33 O Pfaar  31   34 S Shamai  32   33 M Bewick  35 D Ryan  36   37 A Sheikh  6 J M Anto  38   39   40   41 V Cardona  42 J Mullol  43 A Valero  44 N H Chavannes  45 W J Fokkens  46 S Reitsma  46 R E Roller-Wirnsberger  47 P V Tomazic  48 T Haahtela  49 S Toppila-Salmi  49 E Valovirta  50 M Makris  51   52 N G Papadopoulos  51   52 E P Prokopakis  53 F Psarros  54 B Gemicioğlu  55 A Yorgancioglu  56 C Bindslev-Jensen  57 E Eller  57 I Kull  58 M Wickman  59 C Bachert  60 P W Hellings  61   62   63 B Pugin  63 S Bosnic-Anticevich  64 R E O'Hehir  65   66 V Kolek  67 M Sova  67 K Wehner  68 G De Vries  69 M van Eerd  69 D Laune  1 J Wittmann  2 J Bousquet  63   70   71 P Poncelet  72 MASK study group
Collaborators, Affiliations

Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study

D Samreth et al. World Allergy Organ J. .

Abstract

Background: Collecting data on the localization of users is a key issue for the MASK (Mobile Airways Sentinel networK: the Allergy Diary) App. Data anonymization is a method of sanitization for privacy. The European Commission's Article 29 Working Party stated that geolocation information is personal data.To assess geolocation using the MASK method and to compare two anonymization methods in the MASK database to find an optimal privacy method.

Methods: Geolocation was studied for all people who used the Allergy Diary App from December 2015 to November 2017 and who reported medical outcomes. Two different anonymization methods have been evaluated: Noise addition (randomization) and k-anonymity (generalization).

Results: Ninety-three thousand one hundred and sixteen days of VAS were collected from 8535 users and 54,500 (58.5%) were geolocalized, corresponding to 5428 users. Noise addition was found to be less accurate than k-anonymity using MASK data to protect the users' life privacy.

Discussion: k-anonymity is an acceptable method for the anonymization of MASK data and results can be used for other databases.

Keywords: Anonymization; App; Asthma; MASK; Rhinitis.

PubMed Disclaimer

Conflict of interest statement

No ethical committee was required for the study.Not needed. JB reports personal fees and other from Chiesi, Cipla, Hikma, Menarini, Mundipharma, Mylan, Novartis, Sanofi-Aventis, Takeda, Teva, Uriach, other from Kyomed, outside the submitted work.RA reports grants from North Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL2020 Partnership Agreement and through the European Regional Development Fund (ERDF), during the conduct of the study.AC reports grants and personal fees from GlaxoSmithKline, personal fees from Boehringer Ingelheim, MEDA Pharma, CHIESI, AstraZeneca, om Merck, Sharp & Dohme, Novartis EUROFARMA outside the submitted work.H reports personal fees from Munidpharma, Novartis, OrionPharma, outside the submitted work. PK reports personal fees from Adamed, Boehringer Ingelheim, AstraZeneca, Chiesi, FAES, Berlin Chemie, Novartis, Polpharma, Allergopharma, outside the submitted work.V.K has received payment for consultancy from GSK and for lectures from StallergensGreer, Berlin-CHemie outsaide the submitted work.LL reports personal fees from MSD, Pfizer, GSK, Astrazeneca, MEDA, Boehringer Ingelheim, Novartis, Grunenthal, UCB, TEVA, Amstrong, Siegfried, DBV Technologies, grants from Sanofi, Pfizer, Astrazeneca, Novartis, UCB, outside the submitted work.RM reports personal fees from ALK, allergopharma, Allergy Therapeutics, Bayer, Friulchem, FAES, GSK, Hexal, Servier, Klosterfrau, MSD, Johnson&Johnson, Meda, Stada, UCB, Nuvo; grants and personal fees from Bencard, Stallergenes; grants from Leti, Optima, ASIT biotech, BitopAG, Hulka, Ursapharm; grants, personal fees and non-financial support from Lofarma; non-financial support from Atmos, Roxall, Bionorica, Otonomy, Ferrero; personal fees and non-financial support from Novartis; outside the submitted work.NGP reports personal fees from Abbvie Novartis, Faes Farma, BIOMAY, HAL, Nutricia Research, Menarini, Novartis, MEDA, MSD, Omega Pharma, Danone, grants from Menarini, outside the submitted work.0P reports grants and personal fees from ALK-Abelló, Allergopharma, Stallergenes Greer, HAL Allergy Holding B.V./HAL Allergie GmbH, Bencard Allergie GmbH/Allergy Therapeutics, Lofarma, Biotech Tools S.A., Laboratorios LETI/LETI Pharma, Anergis S.A., grants from Biomay, Nuvo, Circassia, Glaxo Smith Kline, personal fees from Novartis Pharma, MEDA Pharma, Mobile Chamber Experts (a GA2LEN Partner), Pohl-Boskamp, Indoor Biotechnologies, grants from, outside the submitted work.RS reports grants from São Paulo Research Foundation, MSD, grants and personal fees from Novartis, grants, personal fees and non-financial support from AstraZeneca, Chiesi, personal fees and non-financial support from Boheringer Ingelheim, outside the submitted work.TBAM reports grants and personal fees from Novartis, Boehringer Ingelheim, Mundipharma, GSK (GlaxoSmithKline), personal fees from Teva Pharma, AstraZeneca, grants from Leti, outside the submitted work. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Geolocation using the ISO/TC211 standards (example: Peercode tester position)
Fig. 2
Fig. 2
Geolocation of VAS days collected in Europe
Fig. 3
Fig. 3
a VAS data of a single “tester”. b Geolocation data treatment with random method blurs, here only one user’s data
Fig. 4
Fig. 4
k-anonymity applied to users in Valenciennes (France)

References

    1. Bousquet J, Hellings PW, Agache I, et al. ARIA 2016: care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy. 2016;6:47. doi: 10.1186/s13601-016-0137-4. - DOI - PMC - PubMed
    1. Caimmi D, Baiz N, Tanno LK, et al. Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control. Clin Exp Allergy. 2017. - PubMed
    1. Bousquet J, Bewick M, Arnavielhe S, et al. Work productivity in rhinitis using cell phones: the MASK pilot study. Allergy. 2017;72:1475–1484. doi: 10.1111/all.13177. - DOI - PubMed
    1. Bousquet J, Caimmi DP, Bedbrook A, et al. Pilot study of mobile phone technology in allergic rhinitis in European countries: the MASK-rhinitis study. Allergy. 2017;72:857–865. doi: 10.1111/all.13125. - DOI - PubMed
    1. Bousquet J, Arnavielhe S, Bedbrook A, et al. The ARIA score of allergic rhinitis using mobile technology correlates with quality-of-life: the MASK study. Allergy. 2018;73(2):505-10. - PubMed